Phase 1 dose-escalation study of SEA-CD40: a non-fucosylated CD40 agonist, in advanced solid tumors and lymphomas

Authors: Thomas F Gajewski, John A Thompson, Sanjay Goel, Brendan D Curti, Elisabeth I Heath, Olivier Rixe, David C Smith, Celine Jacquemont, Tycel Phillips, Martin Gutierrez, Sahar Ansari, Andrew L Coveler, Svetomir N Markovic, Timothy M Kuzel, Amitkumar N Mehta, David L Bajor, Hun Ju Lee, Ajay K Gopal, Paolo Caimi, Ariel Topletz-Erickson, Peigen Zhou, Michael W Schmitt, Juneko E Grilley-Olson

Source: Journal for ImmunoTherapy of Cancer, Vol 11, Iss 6 (2023)

Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://jitc.bmj.com/content/11/6/e005584.full; https://doaj.org/toc/2051-1426

Access URL: https://doaj.org/article/997d45d0420040f2a6abbe4400763c7d

Safety and Efficacy of Toripalimab in Patients with Cholangiocarcinoma: An Open-Label, Phase 1 Study

Authors: Aung Naing, Amit Mahipal, Milind Javle, Judy Wang, Todd M. Bauer, David L. Bajor, Anthony D. Elias, Anthony Shields, Elizabeth Davis, Sant Chawla, Howard Safran, John D. Powderly, Gina D’Amato, Christian F. Meyer, Xiongwen Tang, Sheng Yao, Patricia Keegan

Source: Journal of Immunotherapy and Precision Oncology, Vol 8, Iss 1, Pp 71-81 (2025)

Subject Terms: immune checkpoint inhibitor, programmed cell death (pd-1), refractory cholangiocarcinoma, safety, anti-tumor activity, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282, Immunologic diseases. Allergy, RC581-607

File Description: electronic resource

Relation: https://doaj.org/toc/2666-2345; https://doaj.org/toc/2590-017X

Access URL: https://doaj.org/article/27f5746060b349209b33028213fd4e46

Adoption of single agent anticancer therapy for advanced hepatocellular carcinoma and impact of facility type, insurance status, and income on survival: Analysis of the national cancer database 2004–2014

Authors: Aman Opneja, Gino Cioffi, Asrar Alahmadi, Nelroy Jones, Tin‐Yun Tang, Nirav Patil, David L. Bajor, Joel N. Saltzman, Amr Mohamed, Eva Selfridge, Ankit Mangla, Jill Barnholtz‐Sloan, Richard T. Lee

Source: Cancer Medicine, Vol 10, Iss 13, Pp 4397-4404 (2021)

Subject Terms: chemotherapy, facility type, hepatocellular carcinoma, income, insurance, survival, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/2045-7634

Access URL: https://doaj.org/article/ec0d8868315542849d7c83ead9b2cb93

Associations of Racial and Ethnic Category, Age, Comorbidities, and Socioeconomic Factors on Concordance to NCCN Guidelines for Patients With High-Risk Biliary Tract Cancers After Surgery

Authors: Lauren F. Huang, Augustine Hong, Gino Cioffi, Asrar Alahmadi, Tin-Yun Tang, Lee M. Ocuin, Nirav Patil, David L. Bajor, Joel N. Saltzman, Amr Mohamed, Eva Selfridge, Monica Webb Hooper, Jill Barnholtz-Sloan, Richard T. Lee

Source: Frontiers in Oncology, Vol 12 (2022)

Subject Terms: bile tract cancer, cholangiocarcinoma, health disparities, concordance, race, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2022.771688/full; https://doaj.org/toc/2234-943X

Access URL: https://doaj.org/article/7d5bd437102448b1a668830adaa711ad

Metastatic progression is associated with dynamic changes in the local microenvironment

Authors: Nicole M. Aiello, David L. Bajor, Robert J. Norgard, Amine Sahmoud, Neha Bhagwat, Minh N. Pham, Toby C. Cornish, Christine A. Iacobuzio-Donahue, Robert H. Vonderheide, Ben Z. Stanger

Source: Nature Communications, Vol 7, Iss 1, Pp 1-9 (2016)

Subject Terms: Science

File Description: electronic resource

Relation: https://doaj.org/toc/2041-1723

Access URL: https://doaj.org/article/bf2c2323822742288d632d0fd9cd990d

Long-term outcomes of a phase I study of agonist CD40 antibody and CTLA-4 blockade in patients with metastatic melanoma

Authors: David L. Bajor, Rosemarie Mick, Matthew J. Riese, Alex C. Huang, Brendan Sullivan, Lee P. Richman, Drew A. Torigian, Sangeeth M. George, Erietta Stelekati, Fang Chen, J. Joseph Melenhorst, Simon F. Lacey, Xiaowei Xu, E. John Wherry, Tara C. Gangadhar, Ravi K. Amaravadi, Lynn M. Schuchter, Robert H. Vonderheide

Source: OncoImmunology, Vol 7, Iss 10 (2018)

Subject Terms: cd40, ctla4, melanoma, Immunologic diseases. Allergy, RC581-607, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/2162-402X

Access URL: https://doaj.org/article/db6c0d6d585d48869cc793dff12ef78a